GlassScriptPhysician profile
Mark J Pirwitz
NPI 1063436152
$19,692.03
in general payments reported to CMS, 2019-2025
23 companies · $3,940 in 2025
The $3,940 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,747 · 2020: $739 · 2021: $768 · 2022: $7,497 · 2023: $3,131 · 2024: $1,870 · 2025: $3,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,561 · Travel and Lodging: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,560.83 |
| Travel and Lodging | $1,380.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,143.94 | 2021-2025 | Corevalve Evolut R, Harmony, Micra |
| Edwards Lifesciences Corporation | $3,357.95 | 2022-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $2,977.81 | 2019-2025 | Mitraclip, Triclip, Navitor |
| Abiomed | $1,254.27 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $893.22 | 2019-2020 | |
| Boston Scientific Corporation | $843.77 | 2019-2025 | General - Therapies, Watchman, Watchman Flx |
| Ancora Heart, INC. | $557.36 | 2023-2024 | Accucinch |
| Biotronik INC. | $501.33 | 2019-2023 | Orsiro Mission |
| Heartflow, INC. | $272.79 | 2019-2022 | |
| Cardiva Medical, INC. | $182.67 | 2019-2024 | Optowire |
| Terumo Medical Corporation | $182.39 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.30 | 2019 | |
| Shockwave Medical, INC | $129.91 | 2021 | |
| Endologix LLC | $79.01 | 2019 | |
| Asahi Intecc USA, INC. | $65.14 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $32.78 | 2024 | |
| Siemens Medical Solutions USA, INC. | $22.12 | 2024 | Artis Icono Floor |
| Novartis Pharmaceuticals Corporation | $21.40 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $19.87 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pirwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.